The placebo response of injectable GLP-1 receptor agonists vs. oral DPP-4 inhibitors and SGLT-2 inhibitors: a systematic review and meta-analysis
about
Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis.Safety and tolerability of glucagon-like peptide-1 receptor agonists: unresolved and emerging issues.Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period.Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study
P2860
The placebo response of injectable GLP-1 receptor agonists vs. oral DPP-4 inhibitors and SGLT-2 inhibitors: a systematic review and meta-analysis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The placebo response of inject ...... matic review and meta-analysis
@en
The placebo response of inject ...... atic review and meta-analysis.
@nl
type
label
The placebo response of inject ...... matic review and meta-analysis
@en
The placebo response of inject ...... atic review and meta-analysis.
@nl
prefLabel
The placebo response of inject ...... matic review and meta-analysis
@en
The placebo response of inject ...... atic review and meta-analysis.
@nl
P2093
P2860
P356
P1476
The placebo response of inject ...... matic review and meta-analysis
@en
P2093
Cees J Tack
Helena M de Wit
Maarten Te Groen
P2860
P304
P356
10.1111/BCP.12925
P407
P577
2016-03-03T00:00:00Z